Chapter 1. Executive Summary
Chapter 2. Scope Of The Study
2.1. Market Definition
2.2. Scope Of The Study
2.2.1. Objectives of Report
Chapter 3. Evolve BI Methodology
Chapter 4. Market Insights and Trends
4.1. Supply/ Value Chain Analysis
4.2. Porter’s Five Forces Analysis
4.2.1. Threat Of New Entrants
4.2.2. Bargaining Power Of Buyers
4.2.3. Bargaining Power Of Suppliers
4.2.4. Threat Of Substitutes
4.2.5. Industry Rivalry
4.3. Impact of COVID-19 on Topical Pain Relief Market
4.3.1. Impact on Market Size
4.3.2. End User Trend, Preferences and Budget Impact
4.3.3. Regulatory Framework/Government Policies
4.3.4. Key Players Strategy to Tackle Negative Impact
4.3.5. Opportunity Window
Chapter 5. Market Dynamics
5.1. Introduction
5.2. DRO Analysis
5.2.1. Drivers
5.2.2. Restraints
5.2.3. Opportunities
Chapter 6. Global Topical Pain Relief Market, By Therapeutic Class
6.1. Introduction
6.2. Non-opioids
6.3. Opioids
Chapter 7. Global Topical Pain Relief Market, By Type
7.1. Introduction
7.2. Prescription Pain Relief
7.3. Over-the-counter Pain Relief
Chapter 8. Global Topical Pain Relief Market, By Distribution Channel
8.1. Introduction
8.2. Pharmacy & Drug Store
8.3. e-Commerce
8.4. Retail & Grocery Store
Chapter 9. Global Topical Pain Relief Market, By Region
9.1. Introduction
9.2. North America
9.2.1. Introduction
9.2.2. Driving Factors, Opportunity Analyzed and Key Trends
9.2.3. Market Size and Forecast, By Country, 2020 - 2028
9.2.4. Market Size and Forecast, By Therapeutic Class, 2020 - 2028
9.2.5. Market Size and Forecast, By Type, 2020 - 2028
9.2.6. Market Size and Forecast, By Distribution Channel, 2020 - 2028
9.2.7. US
9.2.7.1. Introduction
9.2.7.2. Driving Factors, Opportunity Analyzed and Key Trends
9.2.7.3. Market Size and Forecast, By Therapeutic Class, 2020 - 2028
9.2.7.4. Market Size and Forecast, By Type, 2020 - 2028
9.2.7.5. Market Size and Forecast, By Distribution Channel, 2020 - 2028
9.2.8. Canada
9.2.8.1. Introduction
9.2.8.2. Driving Factors, Opportunity Analyzed and Key Trends
9.2.8.4. Market Size and Forecast, By Therapeutic Class, 2020 - 2028
9.2.8.5. Market Size and Forecast, By Type, 2020 - 2028
9.2.8.6. Market Size and Forecast, By Distribution Channel, 2020 - 2028
9.3. Europe
9.3.1. Introduction
9.3.2. Driving Factors, Opportunity Analyzed and Key Trends
9.3.3. Market Size and Forecast, By Country, 2020 - 2028
9.3.4. Market Size and Forecast, By Therapeutic Class, 2020 - 2028
9.3.5. Market Size and Forecast, By Type, 2020 - 2028
9.3.6. Market Size and Forecast, By Distribution Channel, 2020 - 2028
9.3.7. Germany
9.3.7.1. Introduction
9.3.7.2. Driving Factors, Opportunity Analyzed and Key Trends
9.3.7.3. Market Size and Forecast, By Therapeutic Class, 2020 - 2028
9.3.7.4. Market Size and Forecast, By Type, 2020 - 2028
9.3.7.5. Market Size and Forecast, By Distribution Channel, 2020 - 2028
9.3.8. France
9.3.8.1. Introduction
9.3.8.2. Driving Factors, Opportunity Analyzed and Key Trends
9.3.8.3. Market Size and Forecast, By Therapeutic Class, 2020 - 2028
9.3.8.4. Market Size and Forecast, By Type, 2020 - 2028
9.3.8.5. Market Size and Forecast, By Distribution Channel, 2020 - 2028
9.3.9. UK
9.3.9.1. Introduction
9.3.9.2. Driving Factors, Opportunity Analyzed and Key Trends
9.3.9.3. Market Size and Forecast, By Therapeutic Class, 2020 - 2028
9.3.9.4. Market Size and Forecast, By Type, 2020 - 2028
9.3.9.5. Market Size and Forecast, By Distribution Channel, 2020 - 2028
9.3.10. Italy
9.3.10.1. Introduction
9.3.10.2. Driving Factors, Opportunity Analyzed and Key Trends
9.3.10.3. Market Size and Forecast, By Therapeutic Class, 2020 - 2028
9.3.10.4. Market Size and Forecast, By Type, 2020 - 2028
9.3.10.5. Market Size and Forecast, By Distribution Channel, 2020 - 2028
9.3.11. Rest Of Europe
9.3.11.1. Introduction
9.3.11.2. Driving Factors, Opportunity Analyzed and Key Trends
9.3.11.3. Market Size and Forecast, By Therapeutic Class, 2020 - 2028
9.3.11.4. Market Size and Forecast, By Type, 2020 - 2028
9.3.11.5. Market Size and Forecast, By Distribution Channel, 2020 - 2028
9.4. Asia-Pacific
9.4.1. Introduction
9.4.2. Driving Factors, Opportunity Analyzed and Key Trends
9.4.3. Market Size and Forecast, By Country, 2020 - 2028
9.4.4. Market Size and Forecast, By Therapeutic Class, 2020 - 2028
9.4.5. Market Size and Forecast, By Type, 2020 - 2028
9.4.7. Market Size and Forecast, By Distribution Channel, 2020 - 2028
9.4.8. China
9.4.8.1. Introduction
9.4.8.2. Driving Factors, Opportunity Analyzed and Key Trends
9.4.8.3. Market Size and Forecast, By Therapeutic Class, 2020 - 2028
9.4.8.4. Market Size and Forecast, By Type, 2020 - 2028
9.4.8.5. Market Size and Forecast, By Distribution Channel, 2020 - 2028
9.4.9. India
9.4.9.1. Introduction
9.4.9.2. Driving Factors, Opportunity Analyzed and Key Trends
9.4.9.3. Market Size and Forecast, By Therapeutic Class, 2020 - 2028
9.4.9.4. Market Size and Forecast, By Type, 2020 - 2028
9.4.9.5. Market Size and Forecast, By Distribution Channel, 2020 - 2028
9.4.10. Japan
9.4.10.1. Introduction
9.4.10.2. Driving Factors, Opportunity Analyzed and Key Trends
9.4.10.3. Market Size and Forecast, By Therapeutic Class, 2020 - 2028
9.4.10.4. Market Size and Forecast, By Type, 2020 - 2028
9.4.10.5. Market Size and Forecast, By Distribution Channel, 2020 - 2028
9.4.11. South Korea
9.4.11.1. Introduction
9.4.11.2. Driving Factors, Opportunity Analyzed and Key Trends
9.4.11.3. Market Size and Forecast, By Therapeutic Class, 2020 - 2028
9.4.11.4. Market Size and Forecast, By Type, 2020 - 2028
9.4.11.5. Market Size and Forecast, By Distribution Channel, 2020 - 2028
9.4.12. Rest Of Asia-Pacific
9.4.11.1. Introduction
9.4.12.2. Driving Factors, Opportunity Analyzed and Key Trends
9.4.12.3. Market Size and Forecast, By Therapeutic Class, 2020 - 2028
9.4.12.4. Market Size and Forecast, By Type, 2020 - 2028
9.4.12.5. Market Size and Forecast, By Distribution Channel, 2020 - 2028
9.5. Rest Of The World (RoW)
9.5.1. Introduction
9.5.2. Driving Factors, Opportunity Analyzed and Key Trends
9.5.3. Market Size and Forecast, By Therapeutic Class, 2020 - 2028
9.5.4. Market Size and Forecast, By Type, 2020 - 2028
9.5.5. Market Size and Forecast, By Distribution Channel, 2020 - 2028
9.5.6. Market Size and Forecast, By Region, 2020 - 2028
9.5.7. South America
9.5.7.1. Introduction
9.5.7.2. Driving Factors, Opportunity Analyzed and Key Trends
9.5.7.3. Market Size and Forecast, By Therapeutic Class, 2020 - 2028
9.5.7.4. Market Size and Forecast, By Type, 2020 - 2028
9.5.7.5. Market Size and Forecast, By Distribution Channel, 2020 - 2028
9.5.8. Middle East & Africa
9.5.8.1. Introduction
9.5.8.2. Driving Factors, Opportunity Analyzed and Key Trends
9.5.8.3. Market Size and Forecast, By Therapeutic Class, 2020 - 2028
9.5.8.4. Market Size and Forecast, By Type, 2020 - 2028
9.5.8.5. Market Size and Forecast, By Distribution Channel, 2020 - 2028
Chapter 10. Competitive Landscape
10.1. Introduction
10.2. Vendor Share Analysis, 2020/Key Players Positioning 2020
Chapter 11. Company Profiles
11.1. Advacare Pharma
11.1.1. Business Overview
11.1.2. Financial Analysis
11.1.3. Product Portfolio
11.1.4. Recent Development and Strategies Adopted
11.1.5. SWOT Analysis
11.2. Glaxosmithkline Plc
11.2.1. Business Overview
11.2.2. Financial Analysis
11.2.3. Product Portfolio
11.2.4. Recent Development and Strategies Adopted
11.2.5. SWOT Analysis
11.3. Johnson & Johnson
11.3.1. Business Overview
11.3.2. Financial Analysis
11.3.3. Product Portfolio
11.3.4. Recent Development and Strategies Adopted
11.3.5. SWOT Analysis
11.4. Nestlé
11.4.1. Business Overview
11.4.2. Financial Analysis
11.4.3. Product Portfolio
11.4.4. Recent Development and Strategies Adopted
11.4.5. SWOT Analysis
11.5. Novartis AG
11.5.1. Business Overview
11.5.2. Financial Analysis
11.5.3. Product Portfolio
11.5.4. Recent Development and Strategies Adopted
11.5.5. SWOT Analysis
11.6. Pfizer Inc
11.6.1. Business Overview
11.6.2. Financial Analysis
11.6.3. Product Portfolio
11.6.4. Recent Development and Strategies Adopted
11.6.5. SWOT Analysis
11.7. Reckitt Benckiser Group Plc
11.7.1. Business Overview
11.7.2. Financial Analysis
11.7.3. Product Portfolio
11.7.4. Recent Development and Strategies Adopted
11.7.5. SWOT Analysis
11.8. Sanofi
11.8.1. Business Overview
11.8.2. Financial Analysis
11.8.3. Product Portfolio
11.8.4. Recent Development and Strategies Adopted
11.8.5. SWOT Analysis
11.9. Sun Pharmaceutical Industries Ltd.
11.9.1. Business Overview
11.9.2. Financial Analysis
11.9.3. Product Portfolio
11.9.4. Recent Development and Strategies Adopted
11.9.5. SWOT Analysis
11.10. Topical Biomedics, Inc.
11.10.1. Business Overview
11.10.2. Financial Analysis
11.10.3. Product Portfolio
11.9.4. Recent Development and Strategies Adopted
11.9.5. SWOT Analysis
Chapter 12. Key Takeaways